Integrated multi-level omics profiling of disulfidptosis identifis SPAG4 as an innovative immunotherapeutic target in glioblastoma

ObjectiveTo investigate the association between disulfidptosis-related genes (DFRGs) and patient prognosis, while concurrently identifying potential therapeutic targets in glioblastoma (GBM).MethodsWe retrieved RNA sequencing data and clinical characteristics of GBM patients from the TCGA database....

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Shenbo Chen, Man Zeng, Taixue Chen, Hui Ding, JiaHan Lin, Fuyue Ye, Ran Wu, Liangwang Yang, Kun Yang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2024-10-01
Sarja:	Frontiers in Immunology
Aiheet:	glioblastoma disulfidptosis tumor immune microenvironment prognostic model SPAG4
Linkit:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1462064/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!